Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling (Phytotherapy Research, 10.1002/ptr.7635)

doi:10.1002/ptr.8144

科研成果详情

名称	Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling (Phytotherapy Research, 10.1002/ptr.7635)
作者	Yang, Na1,2; Zou, Chunpeng3; Luo, Wu 2; Xu, Diyun1,2; Wang, Mengyang1,4; Wang, Yi1; Wu, Gaojun2; Shan, Peiren2; Liang, Guang1,2,5
发表期刊	Phytotherapy Research;
语种	英语
原始文献类型	Erratum
摘要	Corrected article in Phytotherapy Research, Volume 37, Issue 2 The authors regret that two original images (the whole-heart image of the Ang II-Pump+Scl 5 mg/kg group in Figure 1e and the H&E staining image of the Ctrl group in Figure 1H) in this manuscript have been misused. The correct version of Figure 1 including the replaced images in Figure 1e,h is listed below. The authors confirm that the corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience that the errors may have caused. 1 FIGURE (Figure presented.) Sclareol attenuates Ang II-induced cardiac dysfunction in mice with continuous Ang II infusion. (a) Chemical structure of sclareol. (b) Mice systolic blood pressure was determined by a noninvasive tail-cuff pressure analysis system. (c) Body weights of mice were recorded at indicated time points. (d) Ang II levels in the mice serum. (e) Representative macrographs of hearts from different groups of mice. (f) Representative wheat germ agglutinin staining (WGA) staining of heart tissues (scale bar = 50 μm). (g) Quantitative analysis of myocyte area in heart tissue. A minimum of 100 cells were measured from different visual fields of 4 samples per group. (h) Representative hematoxylin–eosin staining of heart sections (scale bar = 30 μm), black arrows indicated myocardial fiber disorganization. Values are mean ± SEM (n = 6 per group). p < 0.01, **p < 0.0001 versus ctrl and Ang II-Pump. Ang II-Pump, Ang II-induced hypertension; Ctrl, control.
ISSN	0951-418X
EISSN	1099-1573
DOI	10.1002/ptr.8144
收录类别	SCOPUS
发布日期	2024
URL	查看原文
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/209000
专题	药学院（分析测试中心）附属第二医院附属第一医院第二临床医学院，附属第二医院、育英儿童医院
通讯作者	Liang, Guang
作者单位	1.Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou,China; 2.Department of Cardiology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China; 3.Department of Ultrasonography,The Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,China; 4.Key Laboratory of Natural Medicines of the Changbai Mountain,Ministry of Education,Yanbian University,Yanji,China; 5.School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou,China
第一作者单位	药学院（分析测试中心）; 附属第一医院
推荐引用方式 GB/T 7714	Yang, Na,Zou, Chunpeng,Luo, Wu,et al. Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling (Phytotherapy Research, 10.1002/ptr.7635). 2024.